Provided by Tiger Trade Technology Pte. Ltd.

Nuo Therapeutics, Inc.

1.60
0.0000
Volume:2.00
Turnover:3.08
Market Cap:76.92M
PE:-31.00
High:1.60
Open:1.60
Low:1.60
Close:1.60
52wk High:3.23
52wk Low:1.00
Shares:48.08M
Float Shares:22.86M
Volume Ratio:0.00
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0516
EPS(LYR):-0.0293
ROE:-1032.50%
ROA:-87.97%
PB:-183.33
PE(LYR):-54.70

Loading ...

Jan 26, 2026

Major Issues Report

Form 8-K - Current report
Dec 17, 2025

Major Issues Report

Form 8-K - Current report
Oct 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 10, 2025

Major Issues Report

Form 8-K - Current report
Jul 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Correspondence

Form CORRESP - Correspondence
Apr 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 10, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 01, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 22, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 19, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
May 21, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 19, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]